Duchenne muscular dystrophy Clinical Trials
Recruiting duchenne muscular dystrophy studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat duchenne muscular dystrophy. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting duchenne muscular dystrophy studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting duchenne muscular dystrophy trials
Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne Muscular Dystrophy Treated in a Post-Marketing Setting
Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy
Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
A Study to Evaluate the Tolerability, Safety and Efficacy of GNR-097 Gene Therapy in Pediatric Patients With Duchenne Muscular Dystrophy
A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)
Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy
Trial of Cell Based Therapy for DMD
Investigation of the Relationship Between Executive Functions and Occupational Performance of Children With Duchenne Muscular Dystrophy
Effectiveness of 5-week Digital Respiratory Practice in Children With Duchenne and Becker Muscular Dystrophies.
Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Then 6 Years Old
Evaluation of Brain Dysfunction in Patients with Duchene Muscular Dystrophy
The U.K. NorthStar Clinical Network
Development of a Registry to Assess Natural History in Duchenne Muscular Dystrophy
Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
Applying the Pathways and Resources for Engagement and Participation Protocol Among People With Muscles Dystrophies
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Vasodilator and Exercise Study for DMD (VASO-REx)
Long Term Follow-up for RGX-202
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
Respiratory Functions, Thoracoabdominal Movements and Exercise Capacity in Neuromuscular Diseases
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD
NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy
An Observational Study Comparing Delandistrogene Moxeparvovec (ELEVIDYS) With Standard of Care in Participants With Duchenne Muscular Dystrophy
A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study
Psychoeducation Program for Parents of Children with Duchenne Muscular Dystrophy
Follow-up Study on Female Carriers With DMD Gene Variants
phenotypeS in Non Ambulant Duchenne Muscular Dystrophy
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
CureDuchenne Link®: A Resource for Research
Once Weekly Infant Corticosteroid Trial for DMD
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study
Natural History of Duchenne Muscular Dystrophy
Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy
A Registered Cohort Study on Duchenne Muscular Dystrophy
A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice
Parent and Infant Inter(X)Action Intervention (PIXI)
Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study
Biomarker Development for Muscular Dystrophies
The Duchenne Registry
Duchenne muscular dystrophy clinical trials — common questions
Are duchenne muscular dystrophy clinical trials free to join?
Yes. Participating in a duchenne muscular dystrophy clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a duchenne muscular dystrophy clinical trial?
Each duchenne muscular dystrophy study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a duchenne muscular dystrophy trial near me?
Use the location controls above. We'll show recruiting duchenne muscular dystrophy trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many duchenne muscular dystrophy trials are recruiting right now?
We're currently tracking roughly 28 recruiting duchenne muscular dystrophy trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.